Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03897049 · ClinicalTrials.gov registry record · NA
Evaluation of the Trans Women Connected Mobile App for Changes in Sexual Health-related Behavior Among Transgender Women
A NA study, sponsored by ETR Associates.
- Completed
- Registry status
- NA
- Development phase
- 574
- Enrollment target
NCT03897049: Completed NA study, sponsored by ETR Associates.
NCT03897049 is a NA study that has completed, run by ETR Associates. The registered enrollment target is 574 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03897049, a NA study, has completed, sponsored by ETR Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 574 participants
- Enrollment target
Study Summary
The study is a 2-arm cluster randomized controlled trial to be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it during a month period. Those in the control arm will be asked to download a general health app and use it during a month period. Participants will complete brief online surveys at baseline, immediately following the app-use period (1-month post baseline), and at 3- and 6-months following baseline. The baseline and follow-up assessments will collect data on demographic characteristics, measures related to our primary and secondary outcomes, and psychosocial measures. The primary outcome measures are self-reported sexually transmitted infection (STI)/HIV testing and sex without a condom, with secondary measures including sexual risk behaviors, health care visits, perceived social support/connectedness, pre-exposure prophylaxis (PrEP) use, self-efficacy in negotiation/communication, and comfort with gender identity and appearance. In addition, process data, such as forum content, and usage data will be collected and analyzed.
Primary Outcome
Participant reported having tested for HIV or STI in the past 3 months
Interventions
- BEHAVIORAL Trans Women Connected
- BEHAVIORAL General Health App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 574 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2022-09-07 |
| Phase | NA |
What the finished NCT03897049 record still lists
NCT03897049 is an interventional study that assigns participants to a tested intervention. The registered 574 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 2 interventions - of which Trans Women Connected is the first listed.
NCT03897049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03897049 about?
NCT03897049 is a clinical study titled "Evaluation of the Trans Women Connected Mobile App for Changes in Sexual Health-related Behavior Among Transgender Women". The study is a 2-arm cluster randomized controlled trial to be conducted with 450 trans women to assess the effectiveness of the Trans Women Connected mobile app. Those in the treatment arm will be provided with the Trans Women Connected app, to be downloaded to their own device, and asked to use it...
What is the current status of trial NCT03897049?
This trial is currently completed. It is a NA study. The enrollment target is 574 participants. The study started on 2021-04-01. Estimated completion is 2022-09-07.
What interventions are being tested in trial NCT03897049?
The interventions under investigation include: Trans Women Connected (BEHAVIORAL), General Health App (BEHAVIORAL).
Who is sponsoring clinical trial NCT03897049?
This trial is sponsored by ETR Associates, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03897049's enrollment target sits among peer trials
574 179th of 2000 higher than 1,822 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07349537 · 574 participants · Phase 1
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- NCT02610439 · 575 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
- NCT05919264 · 575 participants · Phase 1
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- NCT06583148 · 575 participants · NA
A Smoke-Free Home Intervention in Tribal Communities
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI